Chemo-radiotherapy integration in unresectable locally advanced non-small-cell lung cancer: a review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s12094-020-02326-6.pdf
Reference43 articles.
1. Detterbeck FC, Boffa DJ, Kim AW, et al. The eighth edition lung cancer stage classification. Chest. 2017;151(1):193–203.
2. Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally-advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl 4):iv1–21.
3. Beziak A, Temin S, Franklin G, et al. Definitive and adjuvant radiotherapy in locally-advanced non-small-cell lung cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. J Clin Oncol. 2015;33(18):2100–5.
4. Eberhardt W, Bildat S, Korfee S. Combined modality therapy in NSCLC. Ann Oncol. 2000;11(Suppl 3):85–95.
5. Stewart LA, Pignon JP. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ. 1995;311:899–909.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of drug-eluting bead bronchial arterial chemoembolisation in the treatment of non-small cell lung cancer: protocol for a meta-analysis;BMJ Open;2024-06
2. Multi-omics models predict treatment response and overall survival for non-small cell lung cancer patients following chemo-radiotherapy: A multi-center study;2024-03-13
3. Multi-Omics Models Predict Prognosis for Non-Small Cell Lung Cancer Patients Followed Chemotherapy and Radiotherapy: A Multi-Center Study;2024
4. Recent Developments and Challenges in Molecular-Targeted Therapy of Non-Small-Cell Lung Cancer;Journal of Environmental Pathology, Toxicology and Oncology;2023
5. Cutting-edge Nanotechnological Approaches for Lung Cancer Therapy;Current Drug Research Reviews;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3